ACCP "Excellence in Achievement" 

The ACCP "Excellence in Achievement" Program serves to acknowledge ACCP Members whose engagement with ACCP events/committees and contributions to the organization are deserving of recognition.

Bernd Meibohm, PhD, FCP

ACCP is pleased to recognize Bernd Meibohm, PhD, FCP, Professor of Pharmaceutical Sciences and Associate Dean for Research & Graduate Programs at the Coll of Pharmacy, the Univ of Tennessee Health Science Ctr, Memphis, Tennessee. He received his BS in pharmacy and PhD in pharmaceutics from Technical Univ Carolo-Wilhelmina, Braunschweig, Germany. After completion of a clinical pharmacology research fellowship at the Univ of Florida in 1997, he joined the faculty of the Univ of South Carolina and in 1999 the Univ of Tennessee.

Dr. Meibohm’s scientific interests include pulmonary infectious and inflammatory diseases, pediatric pharmacotherapy and the application of quantitative modeling and simulation techniques in preclinical and clinical drug development, with specific focus on therapeutic proteins. His research work has attracted more than $40 million in extramural funding as principal and co-investigator and has resulted in over 180 scientific papers and book chapters (h-index 49), three textbooks, 180 abstracts and over 200 invited scientific presentations to national and international audiences.

Dr. Meibohm is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and the American College of Clinical Pharmacology® (ACCP). He is currently an ACCP Honorary Regent, served on the ACCP Board of Regents (2008 – 2018) and was the President of ACCP (2014 – 2016). Additionally, he has been extensively involved in ACCP committees throughout his membership, such as the Publications Committee (2010 – 2012), Nominating Committee (2012 – 2018), By-laws Committee (2017 – 2018), Honors & Awards Committee (2020 – present) and Annual Meeting Program Committee (2020 – present). Dr. Meibohm has supported ACCP as a Mentor, Faculty Speaker at multiple Annual Meetings and was awarded the Bristol-Myers Squibb Mentorship in Clinical Pharmacology Award in 2017. He also served as 2010 Chair for the ‘Pharmacokinetics, Pharmacodynamics and Drug Metabolism’ (PPDM) section of AAPS and served 2016 – 2019 as Member-at-Large on the Board of Directors of AAPS. He serves as Associate Editor for The AAPS Journal, and is a member of the editorial boards of The Journal of Clinical Pharmacology, Clinical Pharmacokinetics, Journal of Pediatric Pharmacology and Therapeutics, Journal of Pharmacokinetics and Pharmacodynamics, Frontiers in Obstetric and Pediatric Pharmacology, Current Pharmacology Reports, European Journal of Oncology Pharmacy and Die Pharmazie.
Dr. Meibohm kindly shared his thoughts on what ACCP membership means to him:
“ACCP provides a rich, diverse and inclusive environment for scientists from many different professional backgrounds with common interests in clinical pharmacology. For me personally, the society has been a prime source for my professional development and scientific networking activities over nearly 25 years. If I had to decide for one thing to symbolize ACCP, then I would choose a network of bridges that links many different islands to each other. The latter ones represent distinct groups of individuals, for which the society provides the conduit for scientific exchange. These include for example industry, academia and regulatory scientists; MD, PharmD and PhD scientists; clinicians, experimentalists and data scientists; and practitioners, researchers and administrators. Many of us usually spend most of our professional life on one these ‘islands’ and having the opportunity to interact through ACCP with other colleagues from many different professional backgrounds and environments is highly rewarding and allowed me to largely expand my perspectives and understandings relative to clinical pharmacology and beyond.”
Congratulations, Dr. Meibohm, on being recognized for your outstanding achievements and contributions to ACCP! We look forward to your continued support and guidance.